Methods and compositions for modulating the
microbiome of the urogenital region or
skin region of a user are disclosed. The method may include applying a composition to a urogenital region or
skin region of a user, wherein the composition may include a carrier and a therapeutic agent. The therapeutic agent may comprise at least one
prebiotic comprising at least one high molecular weight
dextrin having two or more alpha-1, 6-glycosidic bonds, with or without a cyclic
moiety. The at least one high molecular weight
dextrin having two or more alpha-1, 6-glycosidic bonds comprises a highly branched cyclodextrine, a beta-limit
dextrin, or a combination thereof. The method may also include promoting healthy microbiota balance in the urogenital region or
skin region of the user. Further disclosed is a composition for modulating the
microbiome of the urogenital region or skin region of a user wherein the composition comprises a single
liquid phase comprising an
aqueous solution and a therapeutic agent. The therapeutic agent may comprise at least one
prebiotic compound comprising at least one high molecular weight dextrin having two or more alpha-1, 6-glycosidic bonds, having or not having a cyclic
moiety, such as a highly branched
cyclodextrin, a beta-limit dextrin, or a combination thereof. The disclosed methods and compositions for modulating the
microbiome in the urogenital region or skin region of a user contribute to promoting the growth of healthy
Lactobacillus species, thereby preventing
dysbiosis and other related conditions and infections.